24-hour levodopa-carbidopa intestinal gel may reduce troublesome dyskinesia in advanced Parkinson’s disease

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

C. Warren Olanow, Karl Kieburtz, Per Odin et al. · The Lancet Neurology · 2013 · 683 citations

Advanced Parkinson, Continuous Intrajejunal Infusion, Neurology +3

Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single‐dose challenges

Regina Katzenschlager, Andrew Hughes, Andrew Evans et al. · Movement Disorders · 2004 · 283 citations

Levodopa‐carbidopa intestinal gel in advanced Parkinson's disease: Final 12‐month, open‐label results

Hubert H. Fernandez, David G. Standaert, Robert A. Hauser et al. · Movement Disorders · 2014 · 236 citations · Full text

Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease

M. Maral Mouradian, Isabella J.E. Heuser, Fabio Baronti et al. · Annals of Neurology · 1990 · 235 citations

Advanced Parkinson, Neurophysiology, Medicine +15

Intermittent vs Continuous Levodopa Administration in Patients With Advanced Parkinson Disease

Fabrizio Stocchi, Laura Vacca, Stefano Ruggieri et al. · Archives of Neurology · 2005 · 224 citations